Vitamin D2 vs D3: which is better, and what does “better” mean?
D3 usually raises total vitamin D blood levels more than D2. Two reviews explain the difference—and why a blood-marker result is not a treatment plan.

Complementary human studies · Published 2023–2025
Two supplement boxes, almost the same name, and an unexpected headline: “D2 lowers D3.” It sounds as though one vitamin cancels the other. The missing detail is what the laboratory measured. Once you separate the total from its components, the story becomes much less mysterious.
First, read the blood test correctly
The usual status marker, 25-hydroxyvitamin D or 25(OH)D, contains contributions from D2 and D3. Think of two entries added into one balance. An entry can shrink while the combined balance rises. A headline about the D3 entry alone cannot tell you what happened to the total.
One total. Two contributions.
D2 can raise its contribution while the D3 contribution falls. Check the total before interpreting the headline.
Which form raised the total more?
The earlier review generally favoured D3. In 12 daily-dose comparisons using the same broad laboratory method, the increase with D2 averaged about 10.4 nmol/L less. But results varied substantially across studies. These were blood measurements, not tests of whether D3 prevents more fractures, improves mood or makes someone feel more energetic. Read the comparison review.
That distinction matters at the pharmacy. “Raises a marker more” is a specific advantage; it does not mean “twice as healthy,” or justify doubling a dose. A laboratory result, a diagnosed deficiency and a symptom are three different starting points for a conversation with a clinician.
So why did the newer review find lower D3?
The 2025 review examined the D3-derived component after D2 supplementation. It found a reduction, with substantial variation between trials. D2’s own component may rise at the same time. The authors explicitly leave uncertainty about the clinical meaning when total vitamin D remains adequate. The paper is recent; its evidence search stopped in February 2023. Read the newer review.
The reviews also share some underlying studies. They offer two views of related evidence, rather than two entirely independent sets of people confirming a dramatic new effect. We have kept their participant totals separate.
Does the answer change for Indian readers?
These reviews include evidence from multiple settings, including a UK trial involving South Asian and white European women. They do not provide a nationally representative Indian treatment rule. Where a study was conducted is useful context; it is not a substitute for checking who participated and which outcome was measured.
If your practical question is about a vegetarian product, begin with its label and ingredient source. If it is about a blood report, bring the report and current supplements to the person managing your care. Those questions deserve more than a winner chosen from a headline.
What to remember at the shelf
D3 has the stronger general evidence for raising total 25(OH)D. D2 is not therefore useless, and a fall in one component is not proof of damage. Ask what the number represents before comparing it. This article provides no loading schedule, deficiency threshold or prescription.
Funding is part of that reading too. The 2025 review had UK public research support and disclosed a D3-related company/patent interest. The comparison review disclosed mushroom/D2 and D3-related industry interests. These do not invalidate the results, but they belong beside them rather than disappearing behind the headline.
Sources & further reading
Study years differ from this article’s publication date. We reviewed full primary papers and relevant supporting material; access limitations are kept out of efficacy claims. Original illustrations and diagrams; no publisher figures reproduced. Educational writing, not clinical review.
Published 10 October 2026 · Sources checked 10 October 2026. Suggest a correction.